The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 01, 2022

Filed:

Feb. 26, 2018
Applicant:

Revance Therapeutics, Inc., Newark, CA (US);

Inventor:

Gary E. Borodic, Quincy, MA (US);

Assignee:

Revance Therapeutics, Inc., Newark, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/08 (2006.01); A61K 38/48 (2006.01); A61K 9/06 (2006.01); A61K 9/00 (2006.01); A61P 27/14 (2006.01); A61K 31/198 (2006.01); A61K 31/46 (2006.01); A61K 31/445 (2006.01); A61K 31/196 (2006.01);
U.S. Cl.
CPC ...
A61K 38/4893 (2013.01); A61K 9/0048 (2013.01); A61K 9/06 (2013.01); A61K 9/08 (2013.01); A61P 27/14 (2018.01); A61K 31/196 (2013.01); A61K 31/198 (2013.01); A61K 31/445 (2013.01); A61K 31/46 (2013.01); A61K 2300/00 (2013.01);
Abstract

A composition of botulinum toxin is claimed which can penetrate into the ocular surface inclusive of a penetration through a conjunctiva, cornea, and other structures. This composition allows for a maximal penetration of a topical preparation of botulinum toxin which serves to reduce the need for frequent allergy drops for the treatment of ocular surface disease and other conditions causing ocular surface inflammation or deep ocular inflammation. No puncture of the needle is necessary for the administration. Herein describes a novel composition using several principles based on composition, method of application, which enhances the effectiveness of the penetration.


Find Patent Forward Citations

Borodic, Gary. (2022). Topical ocular preparation of botulinum toxin for use in ocular surface disease (U.S. Patent No. 11484580). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11484580

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…